Wells Fargo analyst Stephen Baxter reiterated a Buy rating on Elevance Health (ELV – Research Report) yesterday and set a price target of ...

In a report released yesterday, Stephen Baxter from Wells Fargo reiterated a Buy rating on Molina Healthcare (MOH – Research Report), with a ...

In a report released yesterday, Stephen Baxter from Wells Fargo reiterated a Buy rating on Centene (CNC – Research Report), with a price target ...

The St. Louis Cardinals announced that the Cardinals Hall of Fame and Museum, located on the second floor of Cardinals Nation at Ballpark Village, will unveil its new featured exhibit entitled Growing ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Pope Francis says in a letter to an Italian newspaper that his lengthy illness has helped make "more lucid" to him the ...

In a report released yesterday, Lisa Gill from J.P. Morgan maintained a Hold rating on Teladoc (TDOC – Research Report), with a price target of ...

Truist Financial analyst Les Sulewski maintained a Buy rating on Cormedix (CRMD – Research Report) today. The company’s shares closed last ...

In a report released on March 14, Stephen Baxter from Wells Fargo maintained a Buy rating on Humana (HUM – Research Report), with a price ...

Wells Fargo analyst Stephen Baxter maintained a Buy rating on CVS Health (CVS – Research Report) on March 14 and set a price target of $73.00.

Cardinal Health Inc. closed 3.64% below its 52-week high of $132.84, which the company reached on January 30th.

Polycystic kidney disease (PKD), a family of genetic disorders that causes clusters of cysts to form on the kidney, is among the most common genetic disorders, affecting some 500,000 people in the ...